The chair of Life Science REIT has said the company is considering "all potential opportunities" for creating shareholder value given the "significant headwinds" it has faced since it listed.
In half-year results for the six months to 30 June, the
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
